Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1981-12-22
pubmed:abstractText
The genome structures of herpes simplex virus type 1 (HSV-1)/HSV-2 intertypic recombinants have been previously determined by restriction endonuclease analysis, and these recombinants and their parental strains have been employed to demonstrate that mutations within the HSV DNA polymerase locus induce an altered HSV DNA polymerase activity, exhibiting resistance to three inhibitors of DNA polymerase. The viral DNA polymerases induced by two recombinants and their parental strains were purified and shown to possess similar molecular weights (142,000 to 144,000) and similar sensitivity to compounds which distinguish viral and cellular DNA polymerases. The HSV DNA polymerases induced by the resistant recombinant and the resistant parental strain were resistant to inhibition by phosphonoacetic acid, acycloguanosine triphosphate, and the 2',3'-dideoxynucleoside triphosphates. The resistant recombinant (R6-34) induced as much acycloguanosine triphosphate as did the sensitive recombinant (R6-26), but viral DNA synthesis in infected cells and the viral DNA polymerase activity were not inhibited. The 2',3'-dideoxynucleoside-triphosphates were effective competitive inhibitors for the HSV DNA polymerase, and the Ki values for the four 2',3'-dideoxynucleoside triphosphates were determined for the four viral DNA polymerases. The polymerases of the resistant recombinant and the resistant parent possessed a much higher Ki for the 2',3'-dideoxynucleoside triphosphates and for phosphonoacetic acid than did the sensitive strains. A 1.3-kilobase-pair region of HSV-1 DNA within the HSV DNA polymerase locus contained mutations which conferred resistance to three DNA polymerase inhibitors. This region of DNA sequences encoded for an amino acid sequence of 42,000 molecular weight and defined an active center of the HSV DNA polymerase enzyme.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-13802337, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-14468055, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-14907713, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-166759, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-172658, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-177727, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-180246, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-181531, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-189089, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-202961, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-205546, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-21304, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-223846, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-225553, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-230783, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-232189, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-4304099, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-4304249, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-4312461, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-4354205, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-4372299, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-53071, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-55273, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-6246531, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-6246532, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-6247818, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-6251603, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-6930270, http://linkedlifedata.com/resource/pubmed/commentcorrection/6270349-7192534
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
746-57
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't